Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial)
Titel:
Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial)
Auteur:
Stahler, Arndt Heinemann, Volker Schuster, Veronika Heinrich, Kathrin Kurreck, Annika Gießen-Jung, Clemens Fischer von Weikersthal, Ludwig Kaiser, Florian Decker, Thomas Held, Swantje Graeven, Ullrich Schwaner, Ingo Denzlinger, Claudio Schenk, Michael Neumann, Jens Kirchner, Thomas Jung, Andreas Kumbrink, Jörg Stintzing, Sebastian Modest, Dominik P.